Migraine has traditionally been understood as a neurovascular and neuroinflammatory disorder, but the glymphatic system, a brain-wide waste-clearance network mediated by cerebrospinal fluid and interstitial fluid exchange, has been proposed as a contributor to migraine pathophysiology. This review synthesizes current evidence on the role of glymphatic system dysfunction in migraine onset and chronification, integrating findings from preclinical animal models and multimodal clinical neuroimaging studies. Converging data suggest that cortical spreading depression during migraine attacks induces astrocyte swelling and aquaporin-4 (AQP4) depolarization, leading to physical collapse of the perivascular space, disruption of convective bulk flow, and impaired glymphatic clearance. This clearance failure may prolong the accumulation of nociceptive molecules, including calcitonin gene-related peptide, potassium ions, and glutamate, within the brain parenchyma, thereby exacerbating trigeminovascular sensitization and potentially contributing to migraine chronification. Clinically, alterations in neuroimaging markers such as the diffusion tensor imaging analysis along the perivascular space index and enlarged perivascular spaces have been associated with progressive fluid stagnation and an increased brain age gap in patients with chronic migraine. Glymphatic clearance failure may therefore contribute to the cycle of neuroinflammation and pain that sustains migraine. Future therapeutic strategies may benefit from moving beyond single-receptor blockade toward approaches that normalize the brain microenvironment, potentially by supporting glymphatic clearance through targeted pharmacological interventions and AQP4 channel modulation.
Purpose: This study aimed to examine whether interictal migraine shows neurophysiological patterns aligned with an external major depressive disorder (MDD) reference dataset, using quantitative electroencephalography (qEEG) indices less sensitive to absolute amplifier gain.
Methods Three datasets were analyzed: ds005385 (normative reference, n=608; age-matched subset, 45–70 years, n=309), TDBRAIN (MDD, n=120; insomnia, n=30; healthy controls, n=47), and 25 patients with interictal migraine (chronic migraine, n=7; episodic migraine, n=18; mean age, 60.0 years; female, n=17). Eight candidate qEEG indices were ranked by effect size in TDBRAIN; the aperiodic exponent and frontal-parietal low-beta asymmetry (FP_asym_LowBeta) showed the largest effects and were selected for analysis. Four arousal-state windows were evaluated: eyes-closed resting, hyperventilation, post-hyperventilation 120 seconds, and post-hyperventilation 300 seconds.
Results In TDBRAIN, patients with MDD showed a reduced aperiodic exponent (Cohen’s d=–0.63, p=0.001) and elevated FP_ asym_LowBeta (Cohen’s d=+0.83, p<0.001) versus healthy controls. In migraine, FP_asym_LowBeta was significantly elevated versus the age-matched normative reference after false discovery rate (FDR) correction during hyperventilation (p=0.015), post-hyperventilation 120 seconds (p=0.004), and post-hyperventilation 300 seconds (p=0.003); the eyes-closed resting window showed a nonsignificant trend (p=0.058). Compared with episodic migraine, chronic migraine showed a consistent but exploratory trend toward a lower aperiodic exponent across windows (Cohen’s d=-0.95 to -1.12, using sample-size-weighted pooled standard deviations), though no comparison survived FDR correction. A linear mixed-effects model showed no significant main effect of migraine subtype (p=0.084).
Conclusion Interictal migraine showed preliminary qEEG patterns aligned with those observed in an external MDD reference dataset, particularly in frontal-parietal low-beta asymmetry during hyperventilation and recovery. However, these exploratory findings require validation in larger, age-matched cohorts with appropriate control for medication use and mood-related confounders.
Morning headaches, which are defined by occurrence upon or shortly after waking up in the morning, range from mild discomfort to severe pain and significantly impact an individual’s quality of life. Although morning headaches are a prevalent and potentially debilitating condition, the criteria for defining these headaches vary. The lack of universally accepted diagnostic criteria complicates understanding their etiology, associated factors, and potential interventions. The causes of morning headaches are multifaceted, including primary headache disorders like migraines and cluster headaches, and secondary causes such as sleep disorders, hypertension, abnormal intracranial pressure, and brain parenchymal diseases. Psychological factors, including anxiety and depression, as well as substance use, further complicate the clinical presentation, often requiring a multidisciplinary approach for effective diagnosis and treatment. This review provides a comprehensive overview of morning headaches, examining their various aspects and possible treatment options, with the goal of enhancing clinicians’ understanding and management of this common yet often overlooked condition.
Citations
Citations to this article as recorded by
Looking into the Night: The Clinical Significance of Morning Headache Soo-Kyoung Kim Headache and Pain Research.2026; 27(2): 73. CrossRef
Comments on “Morning Headaches: An In-Depth Review of Causes, Associated Disorders, and Management Strategies” Seong Taek Kim Headache and Pain Research.2026; 27(2): 165. CrossRef
Sleep Bruxism as a Contributing Factor to Morning Headache: A Response to Recent Commentary Yooha Hong, Hee-Jin Im Headache and Pain Research.2026; 27(2): 167. CrossRef
Morning Headaches as a Specific Obstructive Sleep Apnea Characteristic in a Large Sleep Clinic Population Aliki Karkala, Alexandros Kalkanis, Serafeim-Chrysovalantis Kotoulas, Şakir Kaan Çetindağ, Dries Testelmans, Vasileios Paraschou, Dionisios Spyratos, Dimitrios G. Raptis, Paschalis Steiropoulos, Athanasia Pataka Life.2026; 16(8): 1239. CrossRef
STOP-Bang Modification for Screening Treatment-Relevant Obstructive Sleep Apnea in Cluster Headache: A Retrospective Cohort Study Mi-Kyoung Kang, Yooha Hong, Hee-Jin Im, Jinseob Kim, Soo-Jin Cho Journal of Clinical Medicine.2026; 15(15): 5952. CrossRef
Is craniofacial pain associated with mental health disorders in adults and older adults in Southern Brazil? Antônio Augusto SCHÄFER, Micaela Rabelo QUADRA, Julia Niero Zanatta STRECK, Vanessa Caldardo Lemes da SILVA, Emilio Luiz STRECK, Marcelo Bighetti TONIOLLO, Fernanda Oliveira MELLER Brazilian Oral Research.2026;[Epub] CrossRef
Purpose: Cognitive decline is a common complaint in young patients with migraine, especially those with depression. Independent of psychiatric factors such as depression, subjective cognitive decline (SCD) is associated with an elevated risk of progression to dementia. This study aimed to investigate patterns of subjective cognitive complaints between migraineurs with or without depression and non-depressed older adults.
Methods This retrospective study included 331 outpatients with SCD (293 from a headache clinic and 38 from a memory clinic). SCD was diagnosed as “yes” based on two questions about SCD. The Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) were used to assess cognitive function. The SCD Questionnaire (SCD-Q) with three subdomains was analyzed to compare SCD between groups.
Results Among patients with SCD, significant differences in duration of education were found among the groups—specifically, migraineurs with depression (12.39 years) had longer education than non-depressed older adults (10.50 years) and shorter education than migraineurs without depression (14.28 years). The total MMSE and MoCA scores did not differ between migraineurs with and without depression. Regarding SCD-Q scores, migraineurs with depression showed higher scores overall and in all cognitive domains than migraineurs without depression, with no significant difference compared to non-depressed older adults.
Conclusion Although the depressed migraineurs with SCD were younger and more educated than the non-depressed older adults with SCD, both groups reported similarly high levels of SCD. Higher levels of surveillance for cognitive decline are warranted for migraineurs with depression who have SCD.
Citations
Citations to this article as recorded by
Response to Comments on “Subjective Cognitive Decline Patterns in Patients with Migraine, with or without Depression, versus Non-Depressed Older Adults Sun Hwa Lee, Soo-Jin Cho Headache and Pain Research.2026; 27(3): 266. CrossRef
Comment on “Subjective Cognitive Decline Patterns in Patients with Migraine, with or without Depression, versus Non-depressed Older Adults” Jong-Hee Sohn Headache and Pain Research.2026; 27(3): 263. CrossRef